{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:29:40Z","timestamp":1761290980439},"reference-count":29,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1179\/joc.2007.19.5.582","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T18:06:04Z","timestamp":1389290764000},"page":"582-589","source":"Crossref","is-referenced-by-count":11,"title":["Mitoxantrone Plus Vinorelbine in Pretreated Patients with Metastatic Breast Cancer"],"prefix":"10.1080","volume":"19","author":[{"given":"A.","family":"Onyenadum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gogas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Markopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bafaloukos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Aravantinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mantzourani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Koutras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tzorakoelefterakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Xiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Makatsoris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.P.","family":"Kalofonos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.50.1.7"},{"key":"CIT0002","unstructured":"Hayes DF, Henderson IC, Shapiro CL. Treatment of metastatic breast cancer: present and future prospects. Semin Oncol 1995; 22 (suppl 5): 5-21."},{"key":"CIT0003","first-page":"19","volume":"21","author":"Norton L","year":"1994","journal-title":"Semin Oncol"},{"key":"CIT0004","first-page":"163","volume":"70","author":"Norton L","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"CIT0005","first-page":"389","volume":"24","author":"Silvestris N","year":"2004","journal-title":"Int J Oncol"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/0305-7372(83)90020-8"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198910000-00006"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/1120009X.1993.11739208","volume":"5","author":"Brufman G","year":"1993","journal-title":"J Chemother"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/030089169908500610","volume":"85","author":"Susnjar S","year":"1999","journal-title":"Tumori"},{"key":"CIT0010","unstructured":"Vogel Cl. Combination of chemotherapy with vinorel-bine and mitoxantrone for metastatic breast cancer: a review. Sem Oncol 1995; 22 (Suppl.) 5: 61-65."},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Bruno S, Puerto VL, Mickiewicz E, et al. Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience. Am J Clin Oncol. 1995; 18 (5): 392-6.","DOI":"10.1097\/00000421-199510000-00006"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1200\/JCO.1993.11.7.1245","volume":"11","author":"Fumoleau P","year":"1993","journal-title":"J Clin Oncol"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/JCO.1994.12.2.336","volume":"12","author":"Romero A","year":"1994","journal-title":"J Clin Oncol"},{"issue":"11","key":"CIT0014","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1200\/JCO.1995.13.11.2722","volume":"13","author":"Weber BL","year":"1995","journal-title":"J Clin Oncol"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1159\/000011883"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016075126007"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"CIT0018","first-page":"89","author":"Lentner C","year":"1982","journal-title":"Geigy Scientific Tables (\u2018Exact Confidence Limits for p\u2019); Ciba-Geigy: Switzerland"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00093-4"},{"key":"CIT0020","first-page":"3370","volume":"18","author":"Berruti A","year":"2000","journal-title":"Phase II study of vinorelbine with protracted fluorouracil infusion as a second or third-line approach for advanced breast cancer patients previ-ously treated with anthracyclines. J Clin Oncol"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1007\/BF02614215"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011101)92:9<2267::AID-CNCR1572>3.0.CO;2-Q"},{"key":"CIT0023","first-page":"1","volume":"12","author":"Gasparini G","year":"2094","journal-title":"Barni S et al. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: A phase II study. J Clin Oncol 1994"},{"key":"CIT0024","first-page":"285","volume":"39","author":"Terenziani M","year":"1996","journal-title":"Brambilla C et al. Vinorelbine: An active non-cross resistant drug in advanced breast cancer. Results from a phase II study. Breast Cancer Res Treat"},{"issue":"2","key":"CIT0025","first-page":"207","volume":"23","author":"Terzoli E","year":"2004","journal-title":"J Exp Clin Cancer Res"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyi090"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-004-1000-1"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200209000-00007"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-200029054"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T04:50:34Z","timestamp":1565067034000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.2007.19.5.582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1179\/joc.2007.19.5.582"],"URL":"https:\/\/doi.org\/10.1179\/joc.2007.19.5.582","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}